Kindred Ventures is a seed-stage venture capital fund that supports startup companies. The company prefers to invest in the software, healthcare, telecommunications, retail, climate technology, and consumer industries. It is based in San Francisco, California, and was founded in 2014 by Steve Jang and Kanyi Maqubela.

Kindred Ventures

.406 Ventures is an early-stage venture capital firm that invests in innovative Information Technology (''IT'') and services companies founded by the finest entrepreneurs. They are a veteran team of industry entrepreneurs, operators and investors who apply real world experience, deep industry knowledge and networks, and strong company-building skills to create value for our entrepreneurs and investing partners.   .406 Ventures typically are the lead, first institutional investor in early-stage and de novo investments in market-changing IT Security and Infrastructure, Technology-Enabled Business Services, and Next-Generation Software companies.

.406 Ventures

Optum Ventures provides capital and strategic guidance to startup companies solving health care's pressing challenges. It is the venture capital investment arm of Optum that invests in digital health companies that use data and insights to help improve consumers' access to health care services and how care is delivered and paid for, and that makes the health care system more reliable and easier to navigate.

Optum Ventures

Lerer Hippeau is a seed-stage venture capital firm founded and operated in New York City. Since 2010, they have invested in entrepreneurs with great ideas who aren’t afraid to do hard things. Their portfolio includes more than 400 enterprise and consumer businesses including Guideline, MIRROR, Blockdaemon, K Health, Allbirds, ZenBusiness, and Thrive. They’re experienced operators who invest early and stay in their founders’ corners as they build iconic companies.

Lerer Hippeau

Designer Fund invests in tech startups that are design leaders including Stripe, Gusto, and Omada Health. Designer Fund specializes in helping design products and scales design teams through their professional development programs Bridge and Designer Founder Guild. Their community includes exceptional designer founders and design leaders from companies like Apple, Facebook, Google, Airbnb, Pinterest, and Dropbox.

Designer Fund

Max Ventures is a seed-stage venture capital firm that invests in consumer tech and health-tech companies. Max Ventures primarily invests in digital commerce, digital media, fintech, and digital Health. It was founded in 2013 and headquartered in New York, United States.

Max Ventures

Echo Health Ventures is a venture capital firm that focuses on investing in health care companies. From offices in Durham, Portland, and Seattle, Echo Health Ventures invests in health care companies. They work with portfolio companies to accelerate their innovations to scale nationally. As stage-agnostic investors, they are committed to a new approach to strategic investing – an approach that brings more than capital to the table, an approach focused on developing deep, high-value relationships with their portfolio companies.

Echo Health Ventures

DaVita Venture Group is committed to building partnerships with health care innovators to help improve the lives of patients with kidney disease. Together, we believe we can transform the future of patient care for the better. DaVita Venture Group is part of DaVita Inc., a Fortune 500® health care provider focused on transforming care delivery to patients around the globe. We aim to invest in, develop and launch products, solutions and businesses that improve care for patients with kidney disease and related conditions. Bringing patient-centered chronic care to scale requires reimagining health care as it exists today. As a result, DaVita Venture Group targets companies and products that support our vision across a few key areas of focus: Digital Health: Digitally enabled products and services that leverage technology, data and connectivity to improve care delivery. Pharmaceuticals and Medical Devices: Products that will improve clinical outcomes and patient experience while reducing costs for the health care system. Care Delivery Models: Advancements that expand access to care and improve clinical outcomes by accelerating the adoption of home treatments and value-based care.

DaVita Venture Group

Cressey & Company is a private investment firm focused exclusively on investing in and building leading healthcare businesses.

Cressey & Company

Heartbeat Health

Heartbeat Health is a healthcare technology company that delivers virtual-first cardiovascular disease prevention and management. Through its data-powered platform and clinical services, the company helps patients and at-risk organizations benefit from higher-value care by reducing cardiovascular risk and the likelihood of future adverse events. It offers tools and resources critical to supporting digital care by virtually connect patients with doctors securely and helps in sharing information in real-time, and collaborate on treatment and diet consultation, and helps patients to keep track of their heart health and be in touch with a cardiologist.

Heartbeat is a New York-based startup facilitating reactive cardiac care to proactive care leveraging remote monitoring technologies and telemedicine services. Heartbeat will track cardiac vitals of users through wearables and use online diagnostic questionnaires to recommend follow-up hospital visits for electrocardiograms (ECG) and other advanced cardiac tests if necessary. The service also helps patients correctly interpret the results of their wearables and prescribes diets and physical exercise routines to improve patients' cardiovascular health for a cost of USD 299 per year.

More important now than ever, telehealth will long outlast the pandemic that drove its growth.

Telehealth

Heartbeat Health Raises Growth Funding From Cressey And Existing Investors

Heartbeat is a New York-based startup facilitating reactive cardiac care to proactive care leveraging remote monitoring technologies and telemedicine services. Heartbeat will track cardiac vitals of users through wearables and use online diagnostic questionnaires to recommend follow-up hospital visits for electrocardiograms (ECG) and other advanced cardiac tests if necessary. The service also helps patients correctly interpret the results of their wearables and prescribes diets and physical exercise routines to improve patients' cardiovascular health for a cost of USD 299 per year. Key customers and partnershipsIn August 2023 Hearbeat Health partnered with in-home and virtual healthcare provider MedArrive to provide in-home cardiac care services. Through this partnership, MedArrive will offer Heartbeat Health’s cardiac services to patients of health plans working with MedArrive, with a special focus given to health plans working with Medicaid beneficiaries. Funding and financialsIn May 2021, Heartbeat Health raised USD 20 million in a Series B funding round which will be directed towards research and development of the company’s product offering and enhancing the clinical services provided to at-risk organizations. As of November 2021, the company served more than 60,000 patients from primary care providers, long-term care facilities, and employers. During the same month, Heartbeat Health partnered with healthcare-focused smart device developer, Withings, to launch its ECG smartwatch across the US.

<div>
 
 Nice Healthcare is a US based telehealth company with a focus on primary care services to business-to-business (B2B) clients. Once the employer signs its employees with Nice (at a cost of USD 30 to USD 36 per employee per month), employees do not have to incur out of pocket expenses for Nice services and can schedule virtual or home visits within the time frames specified by the company. It connects patients with practitioners through a mobile app over video calls or text messages. Members can also request home visits which will be completed within a few hours, as claimed by the company. As of March 2022, Nice was operating in twelve states, and had over 400 small and medium enterprises (SMEs).
 
 
 In March 2022, the company raised USD 30 million in Series A financing led by DNA Capital which has been earmarked to expand its platform&rsquo;s reach among small and medium businesses. Additionally, the company is hiring three members for its management team to support the continuing growth of the organization.
 
 
 
</div>

Nice Healthcare

Amicomed is a cloud-based Software-as-a-Service (SaaS) platform which provides blood pressure monitoring services. It collects blood pressure data of patients from at-home devices, applies algorithms, and assesses the fluctuations in the blood pressure. Physicians can be connected and provided with blood pressure data of their patients in order to facilitate their workload, enabling more personalized management of patients regarding medication and lifestyle indications.Amicomed can also recommend actionable and personalized lifestyle interventions such as daily diet and exercises via virtual coaching.

Amicomed

Winston is a men’s health telemedicine platform that treats common issues impacting men such as sexual problems, hair loss, acne, and cold sores. Winston allows patients to consult doctors, place orders for prescription drugs, and offers free delivery to the homes of patients.The Toronto-based company aims to avoid men deferring doctor visits or withholding sensitive information. The consultation fee is covered by the provincial health plan, but the prescriptions are billed to the customer.

Winston

<div>
 
 Dialogue partners with employers and health insurers to offer telehealth services to their employees and members. The users have 24/7 access to doctors, nurses, and other healthcare professionals via audio, video, and chat options for wide arrays of physical and mental health needs, artificial intelligence-enabled (AI-enabled) triage, referrals, and prescription renewals. 
 
 
 The company launched its trademarked Integrated Health Platform in January 2021 to consolidate its virtual care, wellness programs, mental healthcare services, and Employee Assistance Program (EAP) onto a single platform. The company claims to be the only integrated health and wellness B2B platform in Canada. 
 
 
 Key Customers and partnerships
 
 
 Dialogue had direct relationships with over 2,000 customers across Canada and Germany as of December 2020 and served around 50,000 organizations through these partnerships. In addition, the number of members with access to the virtual platform topped 1 million in January 2021. 
 
 
 Fundings and financials
 
 
 As of March 2021, Dialogue was planning to raise CAD 100 million (USD 80 million) from an initial public offering that will be listed on the Toronto Stock Exchange under the ticker symbol &ldquo;CARE.&rdquo; 
 
 
 In Q2 2023, net losses reduced significantly YoY to CAD 5.8 million (USD 4.3 million) from CAD 8.4 million (USD 6.3 million) in Q2 2022. Top-line revenue met internal expectations, growing 17.2% YoY to CAD 25.5 million (USD 19.0 million), driven by &nbsp;an increase in new members (by 18.6% YoY), 
 an expansion of the attach rate as existing customers added more services, and full-quarter contributions from Tictrac.
 
 Dialogue Health has not provided any forward-looking guidance as the company has entered into an agreement to be 
 <a href="https://investors.dialogue.co/English/news/news-details/2023/Dialogue-to-be-Acquired-by-Sun-Life/default.aspx">
 acquired by financial services company Sun Life Financial
 </a>
 for a consideration of CAD 365 million (USD 270 million) or CAD 5.15 (USD 3.82) per share. The transaction is expected to close in Q4 2023. Post acquisition, Dialogue will delist from the Toronto Stock Exchange but will continue to operate as a standalone entity under the &ldquo;Sun Life Canada&rdquo; brand from its head office in Qu&eacute;bec. 
 
 
 
</div>

Dialogue

Grin offers telemedicine and remote monitoring services for orthodontic needs such as braces and teeth straightening. Patients can conduct self-scans (using a Grin device made available to patients in collaboration with 3M) which can be connected to their smartphones and share the feed with orthodontists to access dental solutions. The company plans to go to a subscription-based model after the pandemic. The app also encourages patients to have a 40-second check monthly and share the scan with a dentist in order to allow patients to regularly maintain their dental hygiene.Grin is the only Telehealth disruptor covered on the hub that provides virtual orthopaedic consultations.Funding and financialsIn April 2021, the New York-based teledental platform concluded a seed funding of USD 14 million, and the funds will be allocated to develop additional functionalities by building out its technology. The proceeds will also be used to scale up its team, expand its geographic footprint, and add doctors to the company’s orthodontic partner network.

Grin

Real-time collection of patients’ health-related data using any remote patient monitoring device combined with general telemedicine services to reduce readmission rates. 


A platform that facilitates the transmission of patient data to different locations for further evaluation and interpretation by medical specialists. 


A digital platform that offers specialty care services to address the specific needs of a patient or demographic, including consultations where patients are generally reluctant to meet practitioners face-to-face.

Primary care through virtual consultations for general health-related concerns using a digital platform or mobile app. 

Companies developing B2B software solutions for patient engagement, care navigation, practice management, and electronic health records integration to facilitate telehealth services for healthcare providers. 

IoT is used by most telehealth providers to operate virtual services

All telehealth players are involved in digital health via virtual offerings

Industry players offer varying degrees of personalization for each target audience

Some players offer technology and platforms to healthcare providers, converting physical-only services into virtual services

Specific telehealth offerings focus on diversity and inclusion, providing care to LGBTQ+ or BIPOC populations

Generative AI is used to streamline administrative tasks such as clinical note-taking

<div>
 
 Virtual cardiovascular care provider, Heartbeat Health, has gained unspecified growth funding from many investors, including Cressey &amp; Company, a healthcare-focused investment firm. Heartbeat Health's existing investors such as 406 Ventures, Echo Ventures, Kindred Ventures, and Optum Ventures also participated in this funding round.
 The gathered funds will be utilized by Heartbeat Health to improve its clinical services and care team. Moreover, the company aims to extend its reach to more customers throughout the United States, thereby facilitating the company's overall expansion.
 Heartbeat Health specialises in offering virtual-first prevention and management of cardiovascular diseases. By focusing on clinical experience, health outcomes, and cost reduction, it aims to provide high-value care to patients and organizations at risk. Its platform and clinical services target the reduction of cardiovascular risk and future adverse events.
 
</div>

Heartbeat Health

EDGE Insights

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless